RXFP3 is the cognate receptor for relaxin-3, an abundant brain neuropeptide that acts through a class-A GPCR system to regulate neural network signaling
[1][2]. Mechanistically, RXFP3 couples mainly to Gαᵢ/Gαₒ proteins and engages MAPK pathways including ERK1/2, p38MAPK, and JNK1/2 after ligand activation
[2][3]. In brain systems, relaxin-3/RXFP3 signaling modulates stress responses, anxiety-related behavior, motivated behavior, circadian rhythms, learning, and memory
[1]. In experimental models, central RXFP3 activation disrupted social recognition and increased ERK phosphorylation in specific GABAergic amygdala neurons
[4]. RXFP3-expressing cells in the zona incerta/lateral hypothalamus also projected to stress and arousal centers, and chemogenetic activation increased behavioral arousal in RXFP3-Cre mice
[5]. Compared with related isoforms, RXFP3 differs from RXFP1/RXFP2 systems because relaxin-3 is primarily a neuropeptide, while RXFP3 and RXFP4 share Gαᵢ/Gαₒ coupling
[2]. RXFP3 also differs from RXFP4 because relaxin-3 selectively activates RXFP3, whereas INSL5 is the cognate ligand for RXFP4
[1]. For experimental applications, RXFP3 ligands include peptide agonists, antagonists, biased agonists, and an allosteric modulator, supporting pathway-selective studies and drug-design research
[2][3][6].